Paul Bodfish BSc

Paul Bodfish has spent over 25 years in the clinical research sector in a variety of roles and is an expert in understanding and overcoming the challenges associated with the regulatory and practical elements of successfully running hybrid clinical trials. Paul is one of the original founders of the Medical Research Network and in his current role is responsible for the ongoing development of MRN’s QMS, which continues to evolve as the industry moves into more decentralized trial models. Paul is also MRN’s representative on the IMI Trials@Home consortium, which is a multi-stakeholder team including academia, SMEs, private foundations, and EFPIA members, whose remit is to develop and test remote decentralized methods to streamline data collection, participant recruitment, and retention.